FIFTH AMENDMENT TO CONSOLIDATED EXCLUSIVE AGENCY AND DISTRIBUTION AGREEMENTConsolidated Exclusive Agency and Distribution Agreement • June 9th, 2021
Contract Type FiledJune 9th, 2021This Fifth Amendment to the Consolidated Exclusive Agency and Distribution Agreement (“Fifth Amendment”) is made effective as of [DATE], 2021 (“Fifth Amendment Effective Date”) by and between Dr. Falk Pharma GmbH, a limited liability company incorporated in Germany having its registered office and principal place of business at Leinenweberstraße 5, 79108 Freiburg, Germany (“Falk”) and CMS Bridging Limited, a company incorporated under the laws of Hong Kong registered with the Commercial Register of 65662916 and with its registered office at Unit 2106, 21/F, Island Place Tower, 510 King’s Road, North Point, Hong Kong (“CMS”).